ACOP PULSE

THE QUARTERLY PUBLICATION OF THE AMERICAN COLLEGE OF OSTEOPATHIC PEDIATRICIANS

SPECIAL STUDENT LED & FOCUSED ISSUE


CONTENTS OF THIS ISSUE
Spring-Summer 2021 Issue

Back to Home to Home Page         Print page PRINT PAGE

Meeting of the Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention - June 23, 2021

By Stanley Grogg, DO
Liaison Member for American Osteopathic Association

Coronavirus Disease 1029 (COVID-19) Vaccines

CDC Director, Dr. Wilensky, addressed the ACIP. She thanked the ACIP for the deliberations and time spent for vaccine issues.

The ACIP reviewed data on myocarditis/pericarditis and felt that the benefits of the CoVid-19  clearly outweigh the risks for COVID-19 Vaccine in adolescent/young adults.

As of June 21, 2021 there has been 318 million doses vaccine administered, 150 million people fully vaccinated with 53% of population >12 years of age.

Summary: Myocarditis is the inflamation of the heart muscle and pericartis is inflamation of the lining of the heart. Myopericarditis is the combination of myocarditis and pericarditis. Most cases are of viral etiology. Treatment is primarily supportive thearpy with NSAIDS and exercise restrition while the heart recovers, which is  typically in less than a week. Most recent cases have been in males less than 30 years of age and a few days after the 2nd dose of an mRNA vaccine.

fig 1

CDC's safety monitoring via V-safe, VAERS and locations of the CISA project have resulted in the most intensive vaccine safety monitoring effort in the US History.  (https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety.html)

FDA's member to ACIP suggest a warning be placed in fact sheets given to patients for healthcare providers. Finalized language will be developed.

Why the ACIP recommends CoVid-19 Vaccination to all 12-year-olds and older:   

fig 2

 

fig 3

 

fig 4

 

fig 5

 

Duration of immunity from COVID-19 Vaccination: persistence of antibodies have been demonstrated up to at least 8 months after COVID-10 infection and at least 6 months after 2nd mRNA dose. So far the vaccines are effective for the variants.  In order to stop COVID-19 infections, we MUST get all person 12 years and older vaccinated.

The need for booster immunizations was discussed and recommendations will be made as data is obtained. Presently, no boosters are recommended.

People who are immunocompromised because of cancers, esp. blood cancers, and other conditions may need additional vaccinations and possibly Monoclonal Antibodies.

Any questions, please contact me at stanley.grogg@okstate.edu. If you would like the full minutes, please send me a request.

Back to top

 

WElcome New Members

 


 

JOIN ACOP TODAY!

CLICK HERE

 



2021 Virtual Conference

Support Info

For support and exhibitor information, contact
Dana Gibson